Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Hyaluronidase (recombinant, human) + immune globulin (human)) by Takeda Pharmaceutical for Lymphoma: Likelihood of Approval
(Hyaluronidase (recombinant, human) + immune globulin (human)) is under clinical development by Takeda Pharmaceutical and currently in Phase II for...